Antares Pharma (ATRS) Posts Q4 Loss of 4c/Share
Antares Pharma (NASDAQ: ATRS) reported Q4 EPS of ($0.04), $0.01 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
